Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Carbamoyl Phosphate Synthetase I Deficiency Disease. Data from NIH RePORTER, last 36 months.
Carbamoyl Phosphate Synthetase I Deficiency Disease has emerging NIH research funding with 1 grant totaling $818K.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Carbamoyl Phosphate Synthetase I Deficiency Disease. Strongest funded area: Gene Therapy / Cell Therapy.
1 clinical trial registered but no NIH-funded clinical or translational research grants found for carbamoyl phosphate synthetase I deficiency disease. Trials may be industry-sponsored or funded through non-NIH sources.